Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Global Blood Therapeutics Prices a $200.0 Million Common Stock Public Offering
-
Global Blood Therapeutics (GBT) to sell approximately $200 million in shares of common stock
-
Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
-
Global Blood Therapeutics (GBT) PT Raised to $110 at Cantor Fitzgerald Amid HOPE Trial Results
-
Global Blood Therapeutics (GBT) Says it Priced $150 Million Common Stock Public Offering
-
Global Blood Therapeutics Prices a $150.0 Million Common Stock Public Offering
-
Global Blood Therapeutics (GBT) Announces $150M Offering of Common Stock
-
Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
-
Cantor Fitzgerald Reiterates Bullish View on Global Blood Therapeutics (GBT) on Accelerated Path for Voxelotor
-
UPDATE: Global Blood Therapeutics (GBT) PT Raised to Street High $96 at Cantor Fitzgerald
-
Global Blood Therapeutics (GBT): Look For Efficacy Data From EHA Over The Next Two Days - Cantor
-
Global Blood Therapeutics (GBT) PT Raised to $72 at Cantor Fitzgerald
-
Pre-Open Movers 12/15: (DDR) (ALNY) (HES) Higher; (TROV) (VSTM) (CSX) Lower (more...)
-
Global Blood Therapeutics (GBT) Says it Priced $100M Common Stock Offering
-
Global Blood Therapeutics Prices a $100.0 Million Common Stock Public Offering
-
After-Hours Stock Movers 12/14: (DDR) (HES) (DISCA) Higher; (VSTM) (APHB) (ORCL) Lower (more...)
-
Global Blood Therapeutics (GBT) Announces Proposed $100M Share Common Offering
-
Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
-
Pre-Open Movers 03/16: (GPRO) (ALRM) (ORCL) Higher; (ARTX) (TROV) (GES) Lower (more...)
-
After-Hours Stock Movers 03/15: (ALRM) (FRSH) (GPRO) (ORCL) Higher; (ARTX) (GES) (IPI) Lower (more...)
-
Cantor Fitzgerald Starts Global Blood Therapeutics (GBT) at Overweight, $61 PT
-
Global Blood Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares
-
Global Blood Therapeutics (GBT) Prices Upsized 5.1M Common Stock Offering at $24.50/Share
-
Global Blood Therapeutics Prices a $125.0 Million Upsized Common Stock Public Offering
-
Global Blood Therapeutics (GBT) to Offer $75M in Common Stock
-
Global Blood Therapeutics Announces Proposed Public Offering of Common Stock

